The lung as a route for systemic delivery of therapeutic proteins and peptides

AUTOR(ES)

Uchenna Agu, Remigius

FONTE

BioMed Central

RESUMO

The large surface area, good vascularization, immense capacity for solute exchange and ultra-thinness of the alveolar epithelium are unique features of the lung that can facilitate systemic delivery via pulmonary administration of peptides and proteins. Physical and biochemical barriers, lack of optimal dosage forms and delivery devices limit the systemic delivery of biotherapeutic agents by inhalation. Current efforts to overcome these difficulties in order to deliver metabolic hormones (insulin, calcitonin, thyroid-stimulating hormone [TSH], follicle-stimulating hormone [FSH] and growth hormones) systemically, to induce systemic responses (immunoglobulins, cyclosporin A [CsA], recombinant-methionyl human granulocyte colony-stimulating factor [r-huG-CSF], pancreatic islet autoantigen) and to modulate other biological processes via the lung are reviewed. Safety aspects of pulmonary peptide and protein administration are also discussed.

Documentos Relacionados

• Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins
• A smart approach for delivery of aripiprazole via oro-soft palatal mucosal route for improved therapeutic efficacy
• Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein
• Novel human-derived cell-penetrating peptides for specific subcellular delivery of therapeutic biomolecules